Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    AGN

No quotes available
-- USD   0.00%
07/26 ALLERGAN : Receives Positive Opinion For Truberzi (Eluxadoline) For ..
07/26 ALLERGAN : Allergen receives positive opinion for IBS drug
07/26 ALLERGAN : Gets CHMP Positive Opinion For Truberzi To Treat IBS-D In..
SummaryQuotesNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector news 

Allergan, Inc. : Allergan Gets Subpoena From Government Over Lap-Band System

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/08/2012 | 12:11am CEST
   By Anjali Athavaley 
   Of  
 

Allergan Inc. (AGN) received a subpoena this month from the Department of Health and Human Services requesting documents related to the company's Lap-Band System for obesity, according to a filing.

Lap-Band is approved to help obese patients lose weight. It is inserted surgically through a small incision and placed at the top of the stomach. The inflatable band can be tightened or loosened to reduce or enlarge stomach capacity.

An Allergan spokeswoman declined to comment further.

Earlier this month, Allergan said its first-quarter earnings rose 45% on double-digit sales growth in its specialty-pharmaceuticals business. But sales in Allergan's obesity intervention category slipped 15.5% as high unemployment, lofty co-payments and rigid requirements from insurers pressured sales.

Last December, the U.S. Food and Drug Administration warned nine groups, mostly surgical centers in California, that if they continue misleading advertising for Lap-Band, they could face monetary penalties and have inventory seized. The FDA made no allegations against Allergan at the time.

Allergan shares were up fractionally to $93.79 in after-hours trading Monday. The stock is up nearly 7% so far this year.

-By Anjali Athavaley, Dow Jones Newswires; 212-416-4912; anjali.athavaley@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ALLERGAN, INC.
01:15p ALLERGAN : Assigned Patent
07/26 ALLERGAN : Receives Positive Opinion For Truberzi (Eluxadoline) For Treatment Of..
07/26 ALLERGAN : Allergen receives positive opinion for IBS drug
07/26 ALLERGAN : Gets CHMP Positive Opinion For Truberzi To Treat IBS-D In Adults
07/23 ADAMIS PHARMACEUTICALS : Provides Update On License Agreement with Allergan plc
07/20 Allergan and Adamas Announce New Expanded Indication for NAMZARIC (Memantine ..
07/20 ALLERGAN : Some of the most inventive medicines, devices, and procedures in the ..
07/20 ALLERGAN : FDA approves expanded label for Namzaric in Alzheimer’s disease
07/20 ALLERGAN : Assigned Patent
07/19 SoftBank bid for ARM catches some hedge funds off guard
More news
Sector news : Pharmaceuticals - NEC
05:01pDJGLAXOSMITHKLINE : Helped and Hurt by Sterling's Post-Brexit Fall
03:02pDJBAYER : Reports Higher Second-Quarter Profit, Raises Guidance -- 2nd Update
02:33pDJGLAXOSMITHKLINE : Glaxo Swings to Loss on Write-Down But Core Earnings, Revenue ..
02:06pDJELI LILLY : CEO to Retire
02:06pDJGLAXOSMITHKLINE : Helped and Hurt by Sterling's Post-Brexit Fall
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015 MANNKIND : A Head Pain Gain Or A Pocket-Book Drain?
2015 Tracking Dan Loeb's Third Point Portfolio - Q1 2015 Update
2015 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2015 Update
2015 Time Warner Is A Buy - Cramer's Lightning Round (5/21/15)
2015 Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Ambrose Robert Douglas Bailey Chairman & President
Scott M. Whitcup Chief Scientific Officer & Executive VP-Research
Raymond H. Diradoorian Executive VP-Global Technical Operations
Maria Teresa Hilado Director
Joann Bradley Investor Relations Contact
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN, INC.13.00%0
JOHNSON & JOHNSON21.84%344 243
PFIZER INC.14.10%223 368
NOVARTIS AG-5.30%219 971
ROCHE HOLDING LTD.-9.99%218 902
MERCK & CO., INC.10.49%161 542
More Results